Search Results

Search Results for "risperdal"


  • J&J settles Risperdal lawsuit on first day of trial
    On the first day of trial, Johnson & Johnson settled a lawsuit centering on complaints that its antipsychotic drug Risperdal caused a male plaintiff to grow breasts, Bloomberg reports. The terms of the settlement are confidential. It was the first of about 130 lawsuits alleging that Risperdal ca...
  • Feds want to question new J&J CEO in Risperdal fraud case
    In a motion filed as part of a fraud case against Johnson & Johnson, the federal government alleges that new company CEO Alex Gorsky “was actively involved in matters at issue in this case,” Forbes reports. Government prosecutors charge that Johnson & Johnson paid kickbacks to Omnicare, ...
  • Jury says Johnson & Johnson improperly marketed Risperdal
    A jury in Arkansas ruled that Johnson & Johnson officials used deceptive tactics to market antipsychotic drug Risperdal, misleading doctors about the drug’s risks and improperly marketing it for unapproved uses, Bloomberg reports. The decision in Arkansas marks the third such jury verdict agai...
  • Johnson & Johnson’s 2016 Was Worse Than Yours
    From around September of last year right up until the ball dropped New Year’s Eve, you couldn’t go a day without hearing someone lament just how terrible the year wound up being. From celebrity deaths and other shocking world events to an increasingly hostile political environment, 2016 was the ...
  • Philly Sports Legend Takes on Gynecomastia
    Medical conditions, no matter the type, are hard enough to deal with just by their very presence. The constant struggle to control and, at times, defeat a condition can take a mental toll. The emotional strain and stress that surround illnesses and treatments can be overwhelming. When the condition ...
  • J&J CEO’s Pay Rises 48%
    Johnson & Johnson Chairman and Chief Executive Alex Gorsky’s total pay rose 48 percent in 2014, an article from the Wall Street Journal Reports. Board members say they made the decision based on Johnson & Johnson’s success in achieving short- and long-term financial goals and building ...
  • J&J to Pay Over $2.2 Billion in False Marketing Settlement
    Johnson & Johnson (J&J) and its subsidiaries have agreed to pay over $2.2 billion in criminal and civil fines arising out of false marketing claims.  The company allegedly promoted off-label uses for various drugs, and provided kickbacks to doctors and pharmacists for prescribing those drug...
  • More states pursuing legal action against drug companies
    The Wall Street Journal reports on increasingly aggressive efforts by attorneys general in several U.S. states to pursue legal actions against drug companies for deceptive marketing. Using consumer protection laws as a basis, state officials have gone after some major pharmaceutical companies, inclu...
Page 2 of 5 12345